Opioid Induced Constipation (OIC) Drugs Market Report

Global and China Opioid Induced Constipation (OIC) Drugs Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 05, 2022
  • PAGES：225
  • REPORT CODE：GMM1436566
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Opioid Induced Constipation (OIC) Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • SLA Pharma AG

    • Sucampo Pharmaceuticals

    • Daiichi Sankyo Co Ltd

    • Valeant Pharmaceuticals International

    • Theravance Biopharma Inc

    • Takeda Pharmaceutical Company Limited

    • Purdue Pharma

    • Daewoong Pharmaceutical

    • Shionogi & Co, Ltd

    • Pfizer

    • Ono Pharmaceutical Co, Ltd

    • Cosmo Pharmaceuticals SA

    • CB Fleet Company

    • Allergan Plc

    • Progenics Pharmaceuticals Inc

    • Mundipharma International Limited

    • Ironwood Pharmaceuticals Inc

    • Nektar Therapeutics

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Lubiprostone

    • Methyl Naltrexone Bromide

    • Naldemedine

    • Alvimopan

    • Other

    Application:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Opioid Induced Constipation (OIC) Drugs Industry Overview

      • 1.1.1 Opioid Induced Constipation (OIC) Drugs Market Scope and Market Segments

      • 1.1.2 Opioid Induced Constipation (OIC) Drugs Industry Characteristics

      • 1.1.3 Global and China Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Opioid Induced Constipation (OIC) Drugs Production Value and Growth Rate (2017-2028)

    • 1.2 Global Opioid Induced Constipation (OIC) Drugs Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Lubiprostone

      • 1.2.2 Methyl Naltrexone Bromide

      • 1.2.3 Naldemedine

      • 1.2.4 Alvimopan

      • 1.2.5 Other

    • 1.3 Global Opioid Induced Constipation (OIC) Drugs Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital Pharmacies

      • 1.3.2 Retail Pharmacies

      • 1.3.3 Online Pharmacies

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Opioid Induced Constipation (OIC) Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Opioid Induced Constipation (OIC) Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Opioid Induced Constipation (OIC) Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Opioid Induced Constipation (OIC) Drugs Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Opioid Induced Constipation (OIC) Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Opioid Induced Constipation (OIC) Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Opioid Induced Constipation (OIC) Drugs Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Opioid Induced Constipation (OIC) Drugs Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Opioid Induced Constipation (OIC) Drugs Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Opioid Induced Constipation (OIC) Drugs Industry Porter's Five Forces Model Analysis

      • 2.2.3 Opioid Induced Constipation (OIC) Drugs Industry PEST Analysis

    • 2.3 Opioid Induced Constipation (OIC) Drugs Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Opioid Induced Constipation (OIC) Drugs Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Opioid Induced Constipation (OIC) Drugs Industry

    Chapter 3 Global and China Opioid Induced Constipation (OIC) Drugs Market, by Manufacturer

    • 3.1 Global and China Opioid Induced Constipation (OIC) Drugs Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Opioid Induced Constipation (OIC) Drugs Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Opioid Induced Constipation (OIC) Drugs Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Opioid Induced Constipation (OIC) Drugs Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Opioid Induced Constipation (OIC) Drugs Market Top 3 Players

    Chapter 4 Global and China Opioid Induced Constipation (OIC) Drugs Market, by Type (2017-2028)

    • 4.1 Opioid Induced Constipation (OIC) Drugs Market Trend, by Type

    • 4.2 Global Opioid Induced Constipation (OIC) Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Opioid Induced Constipation (OIC) Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Opioid Induced Constipation (OIC) Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Opioid Induced Constipation (OIC) Drugs Price Trend, by Type (2017-2028)

    • 4.3 China Opioid Induced Constipation (OIC) Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Opioid Induced Constipation (OIC) Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Opioid Induced Constipation (OIC) Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Opioid Induced Constipation (OIC) Drugs Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Opioid Induced Constipation (OIC) Drugs Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Opioid Induced Constipation (OIC) Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Opioid Induced Constipation (OIC) Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Opioid Induced Constipation (OIC) Drugs Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Opioid Induced Constipation (OIC) Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Opioid Induced Constipation (OIC) Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Opioid Induced Constipation (OIC) Drugs Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Opioid Induced Constipation (OIC) Drugs Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Opioid Induced Constipation (OIC) Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Opioid Induced Constipation (OIC) Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Opioid Induced Constipation (OIC) Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Opioid Induced Constipation (OIC) Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Opioid Induced Constipation (OIC) Drugs Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Opioid Induced Constipation (OIC) Drugs Market Analysis

    • 7.1 North America Opioid Induced Constipation (OIC) Drugs Market, by Type

    • 7.2 North America Opioid Induced Constipation (OIC) Drugs Market, by Application

    • 7.3 North America Opioid Induced Constipation (OIC) Drugs Market Analysis and Forecast, by Country

      • 7.3.1 United States Opioid Induced Constipation (OIC) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Opioid Induced Constipation (OIC) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Opioid Induced Constipation (OIC) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Opioid Induced Constipation (OIC) Drugs Market Analysis

    • 8.1 Europe Opioid Induced Constipation (OIC) Drugs Market, by Type

    • 8.2 Europe Opioid Induced Constipation (OIC) Drugs Market, by Application

    • 8.3 Europe Opioid Induced Constipation (OIC) Drugs Market Analysis and Forecast, by Country

      • 8.3.1 Germany Opioid Induced Constipation (OIC) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Opioid Induced Constipation (OIC) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Opioid Induced Constipation (OIC) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Opioid Induced Constipation (OIC) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Opioid Induced Constipation (OIC) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Opioid Induced Constipation (OIC) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Opioid Induced Constipation (OIC) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Opioid Induced Constipation (OIC) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Opioid Induced Constipation (OIC) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Opioid Induced Constipation (OIC) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Opioid Induced Constipation (OIC) Drugs Market Analysis

    • 9.1 APAC Opioid Induced Constipation (OIC) Drugs Market, by Type

    • 9.2 APAC Opioid Induced Constipation (OIC) Drugs Market, by Application

    • 9.3 APAC Opioid Induced Constipation (OIC) Drugs Market Analysis and Forecast, by Country

      • 9.3.1 China Opioid Induced Constipation (OIC) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Opioid Induced Constipation (OIC) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Opioid Induced Constipation (OIC) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Opioid Induced Constipation (OIC) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Opioid Induced Constipation (OIC) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Opioid Induced Constipation (OIC) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Opioid Induced Constipation (OIC) Drugs Market Analysis

    • 10.1 Latin America, Middle East and Africa Opioid Induced Constipation (OIC) Drugs Market, by Type

    • 10.2 Latin America, Middle East and Africa Opioid Induced Constipation (OIC) Drugs Market, by Application

    • 10.3 Latin America, Middle East and Africa Opioid Induced Constipation (OIC) Drugs Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Opioid Induced Constipation (OIC) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Opioid Induced Constipation (OIC) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Opioid Induced Constipation (OIC) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Opioid Induced Constipation (OIC) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Opioid Induced Constipation (OIC) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Opioid Induced Constipation (OIC) Drugs Company Profiles

      • 11.1 SLA Pharma AG

        • 11.1.1 SLA Pharma AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 SLA Pharma AG Opioid Induced Constipation (OIC) Drugs Product Profiles, Application and Specification

        • 11.1.3 SLA Pharma AG Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Sucampo Pharmaceuticals

        • 11.2.1 Sucampo Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product Profiles, Application and Specification

        • 11.2.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Daiichi Sankyo Co Ltd

        • 11.3.1 Daiichi Sankyo Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Product Profiles, Application and Specification

        • 11.3.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Valeant Pharmaceuticals International

        • 11.4.1 Valeant Pharmaceuticals International Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Valeant Pharmaceuticals International Opioid Induced Constipation (OIC) Drugs Product Profiles, Application and Specification

        • 11.4.3 Valeant Pharmaceuticals International Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Theravance Biopharma Inc

        • 11.5.1 Theravance Biopharma Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Product Profiles, Application and Specification

        • 11.5.3 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Takeda Pharmaceutical Company Limited

        • 11.6.1 Takeda Pharmaceutical Company Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Product Profiles, Application and Specification

        • 11.6.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Purdue Pharma

        • 11.7.1 Purdue Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Product Profiles, Application and Specification

        • 11.7.3 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Daewoong Pharmaceutical

        • 11.8.1 Daewoong Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Product Profiles, Application and Specification

        • 11.8.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Shionogi & Co, Ltd

        • 11.9.1 Shionogi & Co, Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Shionogi & Co, Ltd Opioid Induced Constipation (OIC) Drugs Product Profiles, Application and Specification

        • 11.9.3 Shionogi & Co, Ltd Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Pfizer

        • 11.10.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Pfizer Opioid Induced Constipation (OIC) Drugs Product Profiles, Application and Specification

        • 11.10.3 Pfizer Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Ono Pharmaceutical Co, Ltd

        • 11.11.1 Ono Pharmaceutical Co, Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Ono Pharmaceutical Co, Ltd Opioid Induced Constipation (OIC) Drugs Product Profiles, Application and Specification

        • 11.11.3 Ono Pharmaceutical Co, Ltd Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Cosmo Pharmaceuticals SA

        • 11.12.1 Cosmo Pharmaceuticals SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Product Profiles, Application and Specification

        • 11.12.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 CB Fleet Company

        • 11.13.1 CB Fleet Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 CB Fleet Company Opioid Induced Constipation (OIC) Drugs Product Profiles, Application and Specification

        • 11.13.3 CB Fleet Company Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 Allergan Plc

        • 11.14.1 Allergan Plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 Allergan Plc Opioid Induced Constipation (OIC) Drugs Product Profiles, Application and Specification

        • 11.14.3 Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 Progenics Pharmaceuticals Inc

        • 11.15.1 Progenics Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product Profiles, Application and Specification

        • 11.15.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.16 Mundipharma International Limited

        • 11.16.1 Mundipharma International Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.16.2 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Product Profiles, Application and Specification

        • 11.16.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.17 Ironwood Pharmaceuticals Inc

        • 11.17.1 Ironwood Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.17.2 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product Profiles, Application and Specification

        • 11.17.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.18 Nektar Therapeutics

        • 11.18.1 Nektar Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.18.2 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Product Profiles, Application and Specification

        • 11.18.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Opioid Induced Constipation (OIC) Drugs Industry Investment Prospect and Risk Assessment

    • 12.1 Opioid Induced Constipation (OIC) Drugs Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Opioid Induced Constipation (OIC) Drugs Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Global Opioid Induced Constipation (OIC) Drugs Production Value and Growth Rate (2017-2028)

    • Figure China Opioid Induced Constipation (OIC) Drugs Production Value and Growth Rate (2017-2028)

    • Figure Global Opioid Induced Constipation (OIC) Drugs Market Size and Growth Rate of Lubiprostone (2017-2028)

    • Figure Global Opioid Induced Constipation (OIC) Drugs Market Size and Growth Rate of Methyl Naltrexone Bromide (2017-2028)

    • Figure Global Opioid Induced Constipation (OIC) Drugs Market Size and Growth Rate of Naldemedine (2017-2028)

    • Figure Global Opioid Induced Constipation (OIC) Drugs Market Size and Growth Rate of Alvimopan (2017-2028)

    • Figure Global Opioid Induced Constipation (OIC) Drugs Market Size and Growth Rate of Other (2017-2028)

    • Figure Global Opioid Induced Constipation (OIC) Drugs Market Size and Growth Rate of Hospital Pharmacies (2017-2028)

    • Figure Global Opioid Induced Constipation (OIC) Drugs Market Size and Growth Rate of Retail Pharmacies (2017-2028)

    • Figure Global Opioid Induced Constipation (OIC) Drugs Market Size and Growth Rate of Online Pharmacies (2017-2028)

    • Figure North America Opioid Induced Constipation (OIC) Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Opioid Induced Constipation (OIC) Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Opioid Induced Constipation (OIC) Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Opioid Induced Constipation (OIC) Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Opioid Induced Constipation (OIC) Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Opioid Induced Constipation (OIC) Drugs Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Opioid Induced Constipation (OIC) Drugs Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Opioid Induced Constipation (OIC) Drugs Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Opioid Induced Constipation (OIC) Drugs Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Opioid Induced Constipation (OIC) Drugs Market Share, by Manufacturer in 2021

    • Figure Global and China Opioid Induced Constipation (OIC) Drugs Market Share, by Manufacturer in 2022

    • Table Global Opioid Induced Constipation (OIC) Drugs Sales Volume, by Type (2017-2028)

    • Table Global Opioid Induced Constipation (OIC) Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Global Opioid Induced Constipation (OIC) Drugs Sales Volume Share, by Type (2017-2028)

    • Table Global Opioid Induced Constipation (OIC) Drugs Sales Value, by Type (2017-2028)

    • Table Global Opioid Induced Constipation (OIC) Drugs Sales Value Share, by Type (2017-2028)

    • Figure Global Opioid Induced Constipation (OIC) Drugs Price Trend, by Type (2017-2028)

    • Table China Opioid Induced Constipation (OIC) Drugs Sales Volume, by Type (2017-2028)

    • Table China Opioid Induced Constipation (OIC) Drugs Sales Volume Share, by Type (2017-2028)

    • Figure China Opioid Induced Constipation (OIC) Drugs Sales Volume Share, by Type (2017-2028)

    • Table China Opioid Induced Constipation (OIC) Drugs Sales Value, by Type (2017-2028)

    • Table China Opioid Induced Constipation (OIC) Drugs Sales Value Share, by Type (2017-2028)

    • Figure China Opioid Induced Constipation (OIC) Drugs Price Trend, by Type (2017-2028)

    • Table Global Opioid Induced Constipation (OIC) Drugs Sales Volume, by Application (2017-2028)

    • Table Global Opioid Induced Constipation (OIC) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Global Opioid Induced Constipation (OIC) Drugs Sales Volume Share, by Application (2017-2028)

    • Table Global Opioid Induced Constipation (OIC) Drugs Sales Value, by Application (2017-2028)

    • Table Global Opioid Induced Constipation (OIC) Drugs Sales Value Share, by Application (2017-2028)

    • Figure Global Opioid Induced Constipation (OIC) Drugs Sales Value Share, by Application (2017-2028)

    • Table China Opioid Induced Constipation (OIC) Drugs Sales Volume, by Application (2017-2028)

    • Table China Opioid Induced Constipation (OIC) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Opioid Induced Constipation (OIC) Drugs Sales Volume Share, by Application (2017-2028)

    • Table China Opioid Induced Constipation (OIC) Drugs Sales Value, by Application (2017-2028)

    • Table China Opioid Induced Constipation (OIC) Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Opioid Induced Constipation (OIC) Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Opioid Induced Constipation (OIC) Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure North America Opioid Induced Constipation (OIC) Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Opioid Induced Constipation (OIC) Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Opioid Induced Constipation (OIC) Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Opioid Induced Constipation (OIC) Drugs Production, Import, Consumption and Export (2017-2022)

    • Table North America Opioid Induced Constipation (OIC) Drugs Sales Volume, by Type (2017-2028)

    • Table North America Opioid Induced Constipation (OIC) Drugs Sales Volume Share, by Type (2017-2028)

    • Figure North America Opioid Induced Constipation (OIC) Drugs Sales Volume Share, by Type (2017-2028)

    • Table North America Opioid Induced Constipation (OIC) Drugs Sales Volume, by Application (2017-2028)

    • Table North America Opioid Induced Constipation (OIC) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure North America Opioid Induced Constipation (OIC) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure United States Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure United States Opioid Induced Constipation (OIC) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Canada Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Opioid Induced Constipation (OIC) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Opioid Induced Constipation (OIC) Drugs Sales Value and Growth Rate (2017-2028)

    • Table Europe Opioid Induced Constipation (OIC) Drugs Sales Volume, by Type (2017-2028)

    • Table Europe Opioid Induced Constipation (OIC) Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Europe Opioid Induced Constipation (OIC) Drugs Sales Volume Share, by Type (2017-2028)

    • Table Europe Opioid Induced Constipation (OIC) Drugs Sales Volume, by Application (2017-2028)

    • Table Europe Opioid Induced Constipation (OIC) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Europe Opioid Induced Constipation (OIC) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Germany Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Opioid Induced Constipation (OIC) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure UK Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure UK Opioid Induced Constipation (OIC) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure France Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure France Opioid Induced Constipation (OIC) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Italy Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Opioid Induced Constipation (OIC) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Opioid Induced Constipation (OIC) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Spain Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Opioid Induced Constipation (OIC) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Opioid Induced Constipation (OIC) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Poland Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Opioid Induced Constipation (OIC) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Russia Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Opioid Induced Constipation (OIC) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Opioid Induced Constipation (OIC) Drugs Sales Value and Growth Rate (2017-2028)

    • Table APAC Opioid Induced Constipation (OIC) Drugs Sales Volume, by Type (2017-2028)

    • Table APAC Opioid Induced Constipation (OIC) Drugs Sales Volume Share, by Type (2017-2028)

    • Figure APAC Opioid Induced Constipation (OIC) Drugs Sales Volume Share, by Type (2017-2028)

    • Table APAC Opioid Induced Constipation (OIC) Drugs Sales Volume, by Application (2017-2028)

    • Table APAC Opioid Induced Constipation (OIC) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure APAC Opioid Induced Constipation (OIC) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Opioid Induced Constipation (OIC) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Japan Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Opioid Induced Constipation (OIC) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Opioid Induced Constipation (OIC) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure India Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure India Opioid Induced Constipation (OIC) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Opioid Induced Constipation (OIC) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Opioid Induced Constipation (OIC) Drugs Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Opioid Induced Constipation (OIC) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Opioid Induced Constipation (OIC) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Opioid Induced Constipation (OIC) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Opioid Induced Constipation (OIC) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Opioid Induced Constipation (OIC) Drugs Sales Value and Growth Rate (2017-2028)

    • Table SLA Pharma AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table SLA Pharma AG Product Profiles, Application and Specification

    • Table SLA Pharma AG Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sucampo Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sucampo Pharmaceuticals Product Profiles, Application and Specification

    • Table Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Daiichi Sankyo Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Daiichi Sankyo Co Ltd Product Profiles, Application and Specification

    • Table Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Valeant Pharmaceuticals International Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Valeant Pharmaceuticals International Product Profiles, Application and Specification

    • Table Valeant Pharmaceuticals International Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Theravance Biopharma Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Theravance Biopharma Inc Product Profiles, Application and Specification

    • Table Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Takeda Pharmaceutical Company Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Takeda Pharmaceutical Company Limited Product Profiles, Application and Specification

    • Table Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Purdue Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Purdue Pharma Product Profiles, Application and Specification

    • Table Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Daewoong Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Daewoong Pharmaceutical Product Profiles, Application and Specification

    • Table Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Shionogi & Co, Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Shionogi & Co, Ltd Product Profiles, Application and Specification

    • Table Shionogi & Co, Ltd Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ono Pharmaceutical Co, Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ono Pharmaceutical Co, Ltd Product Profiles, Application and Specification

    • Table Ono Pharmaceutical Co, Ltd Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Cosmo Pharmaceuticals SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Cosmo Pharmaceuticals SA Product Profiles, Application and Specification

    • Table Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table CB Fleet Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table CB Fleet Company Product Profiles, Application and Specification

    • Table CB Fleet Company Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Allergan Plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Allergan Plc Product Profiles, Application and Specification

    • Table Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Progenics Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Progenics Pharmaceuticals Inc Product Profiles, Application and Specification

    • Table Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Mundipharma International Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Mundipharma International Limited Product Profiles, Application and Specification

    • Table Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ironwood Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ironwood Pharmaceuticals Inc Product Profiles, Application and Specification

    • Table Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Nektar Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Nektar Therapeutics Product Profiles, Application and Specification

    • Table Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US